{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T03:22:52Z","timestamp":1767151372415,"version":"build-2238731810"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2012,3,9]],"date-time":"2012-03-09T00:00:00Z","timestamp":1331251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2012,3,9]],"date-time":"2012-03-09T00:00:00Z","timestamp":1331251200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Gene Ther"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1038\/cgt.2012.6","type":"journal-article","created":{"date-parts":[[2012,3,9]],"date-time":"2012-03-09T06:19:55Z","timestamp":1331273995000},"page":"336-344","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Intratumoral delivery of CD154 homolog (Ad-ISF35) induces tumor regression: analysis of vector biodistribution, persistence and gene expression"],"prefix":"10.1038","volume":"19","author":[{"given":"J","family":"Melo-Cardenas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Urquiza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T J","family":"Kipps","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J E","family":"Castro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,3,9]]},"reference":[{"key":"BFcgt20126_CR1","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.smim.2009.05.010","volume":"21","author":"DY Ma","year":"2009","unstructured":"Ma DY, Clark EA . The role of CD40 and CD154\/CD40L in dendritic cells. Semin Immunol 2009; 21: 265\u2013272.","journal-title":"Semin Immunol"},{"key":"BFcgt20126_CR2","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1182\/blood.V93.6.1992.406k23_1992_2002","volume":"93","author":"R Buhmann","year":"1999","unstructured":"Buhmann R, Nolte A, Westhaus D, Emmerich B, Hallek M . CD40-activated B-cell chronic lymphocytic leukemia cells for tumor immunotherapy: stimulation of allogeneic versus autologous T cells generates different types of effector cells. Blood 1999; 93: 1992\u20132002.","journal-title":"Blood"},{"key":"BFcgt20126_CR3","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1136\/gut.2007.130252","volume":"57","author":"S Serba","year":"2008","unstructured":"Serba S, Schmidt J, Wentzensen N, Ryschich E, M\u00e4rten A . Transfection with CD40L induces tumour suppression by dendritic cell activation in an orthotopic mouse model of pancreatic adenocarcinoma. Gut 2008; 57: 344\u2013351.","journal-title":"Gut"},{"key":"BFcgt20126_CR4","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.it.2011.02.004","volume":"32","author":"A Cerutti","year":"2011","unstructured":"Cerutti A, Puga I, Cols M . Innate control of B cell responses. Trends Immunol 2011; 32: 202\u2013211.","journal-title":"Trends Immunol"},{"key":"BFcgt20126_CR5","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1172\/JCI1472","volume":"101","author":"K Kato","year":"1998","unstructured":"Kato K, Cantwell MJ, Sharma S, Kipps TJ . Gene transfer of CD40-ligand induces autologous immune recognition of chronic lymphocytic leukemia B cells. J Clin Invest 1998; 101: 1133\u20131141.","journal-title":"J Clin Invest"},{"key":"BFcgt20126_CR6","doi-asserted-by":"crossref","first-page":"3853","DOI":"10.1182\/blood.V95.12.3853.012k37_3853_3858","volume":"95","author":"P Chu","year":"2000","unstructured":"Chu P, Wierda WG, Kipps TJ . CD40 activation does not protect chronic lymphocytic leukemia B cells from apoptosis induced by cytotoxic T lymphocytes. Blood 2000; 95: 3853\u20133858.","journal-title":"Blood"},{"key":"BFcgt20126_CR7","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s12307-008-0010-7","volume":"1","author":"CF Chantrain","year":"2008","unstructured":"Chantrain CF, Feron O, Marbaix E, DeClerck YA . Bone marrow microenvironment and tumor progression. Cancer Microenviron 2008; 1: 23\u201335.","journal-title":"Cancer Microenviron"},{"key":"BFcgt20126_CR8","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/nrc1477","volume":"4","author":"MM Mueller","year":"2004","unstructured":"Mueller MM, Fusenig NE . Friends or foes\u2014bipolar effects of the tumour stroma in cancer. Nat Rev Cancer 2004; 4: 839\u2013849.","journal-title":"Nat Rev Cancer"},{"key":"BFcgt20126_CR9","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.ccr.2005.05.024","volume":"7","author":"JA Joyce","year":"2005","unstructured":"Joyce JA . Therapeutic targeting of the tumor microenvironment. Cancer Cell 2005; 7: 513\u2013520.","journal-title":"Cancer Cell"},{"key":"BFcgt20126_CR10","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1182\/blood-2010-05-284984","volume":"117","author":"Y Herishanu","year":"2011","unstructured":"Herishanu Y, P\u00e9rez-Gal\u00e1n P, Liu D, Biancotto A, Pittaluga S, Vire B et al. The lymph node microenvironment promotes B-cell receptor signaling, NF-kappaB activation, and tumor proliferation in chronic lymphocytic leukemia. Blood 2011; 117: 563\u2013574.","journal-title":"Blood"},{"key":"BFcgt20126_CR11","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1126\/science.1198443","volume":"331","author":"GL Beatty","year":"2011","unstructured":"Beatty GL, Chiorean EG, Fishman MP, Saboury B, Teitelbaum UR, Sun W et al. CD40 agonists alter tumor stroma and show efficacy against pancreatic carcinoma in mice and humans. Science 2011; 331: 1612\u20131616.","journal-title":"Science"},{"key":"BFcgt20126_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/sj.cgt.7700527","volume":"10","author":"AW Tong","year":"2003","unstructured":"Tong AW, Stone MJ . Prospects for CD40-directed experimental therapy of human cancer. Cancer Gene Ther 2003; 10: 1\u201313.","journal-title":"Cancer Gene Ther"},{"key":"BFcgt20126_CR13","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.coph.2004.02.008","volume":"4","author":"AG Eliopoulos","year":"2004","unstructured":"Eliopoulos AG, Young LS . The role of the CD40 pathway in the pathogenesis and treatment of cancer. Curr Opin Pharmacol 2004; 4: 360\u2013367.","journal-title":"Curr Opin Pharmacol"},{"key":"BFcgt20126_CR14","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1007\/978-0-387-89520-8_2","volume":"647","author":"CL Law","year":"2009","unstructured":"Law CL, Grewal IS . Therapeutic interventions targeting CD40L (CD154) and CD40: the opportunities and challenges. Adv Exp Med Biol 2009; 647: 8\u201336.","journal-title":"Adv Exp Med Biol"},{"key":"BFcgt20126_CR15","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.1182\/blood.V96.9.2917","volume":"96","author":"WG Wierda","year":"2000","unstructured":"Wierda WG, Cantwell MJ, Woods SJ, Rassenti LZ, Prussak CE, Kipps TJ et al. CD40-ligand (CD154) gene therapy for chronic lymphocytic leukemia. Blood 2000; 96: 2917\u20132924.","journal-title":"Blood"},{"key":"BFcgt20126_CR16","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1038\/leu.2010.191","volume":"24","author":"WG Wierda","year":"2010","unstructured":"Wierda WG, Castro JE, Aguillon R, Sampath D, Jalayer A, McMannis J et al. A phase I study of immune gene therapy for patients with CLL using a membrane-stable, humanized CD154. Leukemia 2010; 24: 1893\u20131900.","journal-title":"Leukemia"},{"key":"BFcgt20126_CR17","unstructured":"Services USDoHaH. In: Administration FaD, Research CfBEa (eds). Guidance for Industry: Gene Therapy Clinical Trials\u2014Observing Subjects for Delayed Adverse Events. B. Considerations for preclinical study design to assess vector biodistribution and persistence. Rockville, MD, USA, 2006."},{"key":"BFcgt20126_CR18","unstructured":"Biosystems A . Creating Standard Curves with Genomic DNA or Plasmid DNA Templates for use in Quantitative PCR. F Hoffmann-La Roche Ltd: Basel."},{"key":"BFcgt20126_CR19","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1080\/01926230600867750","volume":"34","author":"AW Suttie","year":"2006","unstructured":"Suttie AW . Histopathology of the spleen. Toxicol Pathol 2006; 34: 466\u2013503.","journal-title":"Toxicol Pathol"},{"key":"BFcgt20126_CR20","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1007\/s10585-007-9089-3","volume":"24","author":"RS MacGill","year":"2007","unstructured":"MacGill RS, Davis TA, Macko J, Mauceri HJ, Weichselbaum RR, King CR et al. Local gene delivery of tumor necrosis factor alpha can impact primary tumor growth and metastases through a host-mediated response. Clin Exp Metastasis 2007; 24: 521\u2013531.","journal-title":"Clin Exp Metastasis"},{"key":"BFcgt20126_CR21","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1093\/jnci\/djj397","volume":"98","author":"JH Kim","year":"2006","unstructured":"Kim JH, Lee YS, Kim H, Huang JH, Yoon AR, Yun CO . Relaxin expression from tumor-targeting adenoviruses and its intratumoral spread, apoptosis induction, and efficacy. J Natl Cancer Inst 2006; 98: 1482\u20131493.","journal-title":"J Natl Cancer Inst"},{"key":"BFcgt20126_CR22","doi-asserted-by":"publisher","first-page":"9221","DOI":"10.1073\/pnas.97.16.9221","volume":"97","author":"Z Hu","year":"2000","unstructured":"Hu Z, Garen A . Intratumoral injection of adenoviral vectors encoding tumor-targeted immunoconjugates for cancer immunotherapy. Proc Natl Acad Sci USA 2000; 97: 9221\u20139225.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFcgt20126_CR23","first-page":"3625","volume":"7","author":"F Lohr","year":"2001","unstructured":"Lohr F, Huang Q, Hu K, Dewhirst MW, Li CY . Systemic vector leakage and transgene expression by intratumorally injected recombinant adenovirus vectors. Clin Cancer Res 2001; 7: 3625\u20133628.","journal-title":"Clin Cancer Res"},{"key":"BFcgt20126_CR24","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1038\/cgt.2009.27","volume":"16","author":"J Reay","year":"2009","unstructured":"Reay J, Kim SH, Lockhart E, Kolls J, Robbins PD . Adenoviral-mediated, intratumor gene transfer of interleukin 23 induces a therapeutic antitumor response. Cancer Gene Ther 2009; 16: 776\u2013785.","journal-title":"Cancer Gene Ther"},{"key":"BFcgt20126_CR25","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1038\/mt.2008.280","volume":"17","author":"K Pande","year":"2009","unstructured":"Pande K, Ueda R, Machemer T, Sathe M, Tsai V, Brin E et al. Cancer-induced expansion and activation of CD11b+ Gr-1+ cells predispose mice to adenoviral-triggered anaphylactoid-type reactions. Mol Ther 2009; 17: 508\u2013515.","journal-title":"Mol Ther"},{"key":"BFcgt20126_CR26","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1177\/09680519040100060301","volume":"10","author":"C Oberholzer","year":"2004","unstructured":"Oberholzer C, Oberholzer A, Tschoeke SK, Minter RM, Bahjat FR, LaFace D et al. Influence of recombinant adenovirus on liver injury in endotoxicosis and its modulation by IL-10 expression. J Endotoxin Res 2004; 10: 393\u2013401.","journal-title":"J Endotoxin Res"},{"key":"BFcgt20126_CR27","first-page":"2701","volume":"9","author":"PJ Mahasreshti","year":"2003","unstructured":"Mahasreshti PJ, Kataram M, Wang MH, Stockard CR, Grizzle WE, Carey D et al. Intravenous delivery of adenovirus-mediated soluble FLT-1 results in liver toxicity. Clin Cancer Res 2003; 9: 2701\u20132710.","journal-title":"Clin Cancer Res"},{"key":"BFcgt20126_CR28","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.ymthe.2005.08.007","volume":"13","author":"E Manickan","year":"2006","unstructured":"Manickan E, Smith JS, Tian J, Eggerman TL, Lozier JN, Muller J et al. Rapid Kupffer cell death after intravenous injection of adenovirus vectors. Mol Ther 2006; 13: 108\u2013117.","journal-title":"Mol Ther"},{"key":"BFcgt20126_CR29","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1038\/mt.2009.279","volume":"18","author":"Z Xu","year":"2010","unstructured":"Xu Z, Smith JS, Tian J, Byrnes AP . Induction of shock after intravenous injection of adenovirus vectors: a critical role for platelet-activating factor. Mol Ther 2010; 18: 609\u2013616.","journal-title":"Mol Ther"},{"key":"BFcgt20126_CR30","doi-asserted-by":"crossref","first-page":"4990","DOI":"10.1182\/blood.V87.12.4990.bloodjournal87124990","volume":"87","author":"BD Cheson","year":"1996","unstructured":"Cheson BD, Bennett JM, Grever M, Kay N, Keating MJ, O'Brien S et al. National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment. Blood 1996; 87: 4990\u20134997.","journal-title":"Blood"},{"key":"BFcgt20126_CR31","doi-asserted-by":"publisher","first-page":"5446","DOI":"10.1182\/blood-2007-06-093906","volume":"111","author":"M Hallek","year":"2008","unstructured":"Hallek M, Cheson BD, Catovsky D, Caligaris-Cappio F, Dighiero G, D\u00f6hner H et al. Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines. Blood 2008; 111: 5446\u20135456.","journal-title":"Blood"},{"key":"BFcgt20126_CR32","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1089\/10430340152712665","volume":"13","author":"JN Lozier","year":"2002","unstructured":"Lozier JN, Csako G, Mondoro TH, Krizek DM, Metzger ME, Costello R et al. Toxicity of a first-generation adenoviral vector in rhesus macaques. Hum Gene Ther 2002; 13: 113\u2013124.","journal-title":"Hum Gene Ther"},{"key":"BFcgt20126_CR33","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1089\/10430340152712674","volume":"13","author":"TL Eggerman","year":"2002","unstructured":"Eggerman TL, Mondoro TH, Lozier JN, Vostal JG . Adenoviral vectors do not induce, inhibit, or potentiate human platelet aggregation. Hum Gene Ther 2002; 13: 125\u2013128.","journal-title":"Hum Gene Ther"},{"key":"BFcgt20126_CR34","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1046\/j.1365-2141.2003.04719.x","volume":"123","author":"N Wolins","year":"2003","unstructured":"Wolins N, Lozier J, Eggerman TL, Jones E, Aguilar-C\u00f3rdova E, Vostal JG . Intravenous administration of replication-incompetent adenovirus to rhesus monkeys induces thrombocytopenia by increasing in vivo platelet clearance. Br J Haematol 2003; 123: 903\u2013905.","journal-title":"Br J Haematol"},{"key":"BFcgt20126_CR35","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1002\/(SICI)1521-2254(199909\/10)1:5<360::AID-JGM54>3.0.CO;2-Q","volume":"1","author":"G Cichon","year":"1999","unstructured":"Cichon G, Schmidt HH, Benhidjeb T, L\u00f6ser P, Ziemer S, Haas R et al. Intravenous administration of recombinant adenoviruses causes thrombocytopenia, anemia and erythroblastosis in rabbits. J Gene Med 1999; 1: 360\u2013371.","journal-title":"J Gene Med"},{"key":"BFcgt20126_CR36","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1161\/01.RES.0000070111.98158.6C","volume":"92","author":"DP Inwald","year":"2003","unstructured":"Inwald DP, McDowall A, Peters MJ, Callard RE, Klein NJ . CD40 is constitutively expressed on platelets and provides a novel mechanism for platelet activation. Circ Res 2003; 92: 1041\u20131048.","journal-title":"Circ Res"},{"key":"BFcgt20126_CR37","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1160\/TH09-01-0029","volume":"102","author":"D Lievens","year":"2009","unstructured":"Lievens D, Eijgelaar WJ, Biessen EA, Daemen MJ, Lutgens E . The multi-functionality of CD40L and its receptor CD40 in atherosclerosis. Thromb Haemost 2009; 102: 206\u2013214.","journal-title":"Thromb Haemost"},{"key":"BFcgt20126_CR38","doi-asserted-by":"publisher","first-page":"14622","DOI":"10.1128\/JVI.79.23.14622-14631.2005","volume":"79","author":"MJ Cotter","year":"2005","unstructured":"Cotter MJ, Zaiss AK, Muruve DA . Neutrophils interact with adenovirus vectors via Fc receptors and complement receptor 1. J Virol 2005; 79: 14622\u201314631.","journal-title":"J Virol"},{"key":"BFcgt20126_CR39","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1038\/sj.bjc.6602494","volume":"92","author":"Y Wang","year":"2005","unstructured":"Wang Y, Yang Z, Liu S, Kon T, Krol A, Li CY et al. Characterisation of systemic dissemination of nonreplicating adenoviral vectors from tumours in local gene delivery. Br J Cancer 2005; 92: 1414\u20131420.","journal-title":"Br J Cancer"},{"key":"BFcgt20126_CR40","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1158\/1535-7163.MCT-05-0266","volume":"5","author":"Y Wang","year":"2006","unstructured":"Wang Y, Wang H, Li CY, Yuan F . Effects of rate, volume, and dose of intratumoral infusion on virus dissemination in local gene delivery. Mol Cancer Ther 2006; 5: 362\u2013366.","journal-title":"Mol Cancer Ther"},{"key":"BFcgt20126_CR41","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/gt.2008.2","volume":"15","author":"M Bazan-Peregrino","year":"2008","unstructured":"Bazan-Peregrino M, Carlisle RC, Purdie L, Purdie L, Seymour LW . Factors influencing retention of adenovirus within tumours following direct intratumoural injection. Gene Ther 2008; 15: 688\u2013694.","journal-title":"Gene Ther"},{"key":"BFcgt20126_CR42","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.4049\/jimmunol.162.4.2368","volume":"162","author":"T Sparwasser","year":"1999","unstructured":"Sparwasser T, H\u00fcltner L, Koch ES, Luz A, Lipford GB, Wagner H . Immunostimulatory CpG-oligodeoxynucleotides cause extramedullary murine hemopoiesis. J Immunol 1999; 162: 2368\u20132374.","journal-title":"J Immunol"},{"key":"BFcgt20126_CR43","doi-asserted-by":"crossref","first-page":"6729","DOI":"10.1128\/JVI.73.8.6729-6742.1999","volume":"73","author":"BG Harvey","year":"1999","unstructured":"Harvey BG, Hackett NR, El-Sawy T, Rosengart TK, Hirschowitz EA, Lieberman MD et al. Variability of human systemic humoral immune responses to adenovirus gene transfer vectors administered to different organs. J Virol 1999; 73: 6729\u20136742.","journal-title":"J Virol"},{"key":"BFcgt20126_CR44","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1089\/10430340050083289","volume":"11","author":"Y Chen","year":"2000","unstructured":"Chen Y, Yu DC, Charlton D, Henderson DR . Pre-existent adenovirus antibody inhibits systemic toxicity and antitumor activity of CN706 in the nude mouse LNCaP xenograft model: implications and proposals for human therapy. Hum Gene Ther 2000; 11: 1553\u20131567.","journal-title":"Hum Gene Ther"},{"key":"BFcgt20126_CR45","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1038\/sj.gt.3300994","volume":"6","author":"N Chirmule","year":"1999","unstructured":"Chirmule N, Propert K, Magosin S, Qian Y, Qian R, Wilson J . Immune responses to adenovirus and adeno-associated virus in humans. Gene Ther 1999; 6: 1574\u20131583.","journal-title":"Gene Ther"},{"key":"BFcgt20126_CR46","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1038\/sj.gt.3300508","volume":"4","author":"JL Bramson","year":"1997","unstructured":"Bramson JL, Hitt M, Gauldie J, Graham FL . Pre-existing immunity to adenovirus does not prevent tumor regression following intratumoral administration of a vector expressing IL-12 but inhibits virus dissemination. Gene Ther 1997; 4: 1069\u20131076.","journal-title":"Gene Ther"},{"key":"BFcgt20126_CR47","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.virol.2004.01.031","volume":"322","author":"S Mercier","year":"2004","unstructured":"Mercier S, Rouard H, Delfau-Larue MH, Eloit M . Specific antibodies modulate the interactions of adenovirus type 5 with dendritic cells. Virology 2004; 322: 308\u2013317.","journal-title":"Virology"},{"key":"BFcgt20126_CR48","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1089\/hum.1997.8.16-1935","volume":"8","author":"ME Grossmann","year":"1997","unstructured":"Grossmann ME, Brown MP, Brenner MK . Antitumor responses induced by transgenic expression of CD40 ligand. Hum Gene Ther 1997; 8: 1935\u20131943.","journal-title":"Hum Gene Ther"}],"updated-by":[{"DOI":"10.1038\/cgt.2012.44","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2012,7,18]],"date-time":"2012-07-18T00:00:00Z","timestamp":1342569600000}}],"container-title":["Cancer Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/cgt20126.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/cgt20126","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/cgt20126.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,20]],"date-time":"2023-06-20T20:20:17Z","timestamp":1687292417000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/cgt20126"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3,9]]},"references-count":48,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["BFcgt20126"],"URL":"https:\/\/doi.org\/10.1038\/cgt.2012.6","relation":{},"ISSN":["0929-1903","1476-5500"],"issn-type":[{"value":"0929-1903","type":"print"},{"value":"1476-5500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3,9]]},"assertion":[{"value":"24 November 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2012","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2012","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2012","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"TJK receives stock options as a payment for providing consulting services to Memgen LLC. The University of California owns the patent for Ad-ISF35 and licenses it to Memgen LLC. The other authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}